CANTELLI FORTI, GIORGIO
CANTELLI FORTI, GIORGIO
DIPARTIMENTO DI SCIENZE PER LA QUALITA' DELLA VITA
Cantelli Forti G.; G. CANTELLI FORTI; Giorgio Cantelli Forti
Comparison of Adaptive Neuroprotective Mechanisms of Sulforaphane and its Interconversion Product Erucin in in Vitro and in Vivo Models of Parkinson's Disease
2018 Morroni Fabiana, Sita Giulia, Djemil Alice, D'Amico Massimo, Pruccoli Letizia, Cantelli-Forti Giorgio, Hrelia Patrizia, Tarozzi Andrea.
Relationship between lipid phenotypes, overweight, lipid lowering drug response and KIF6 and HMG-CoA genotypes in a subset of the brisighella heart study population
2018 Angelini, Sabrina; Rosticci, Martina; Massimo, Gianmichele; Musti, Muriel; Ravegnini, Gloria; Consolini, Nicola; Sammarini, Giulia; Dâ addato, Sergio; Rizzoli, Elisabetta; Botbayev, Dauren; Borghi, Claudio; Cantelli-Forti, Giorgio; Cicero, Arrigo F.; Hrelia, Patrizia
Antileukemic activity of sulforaphane in primary blasts from patients affected by myelo- and lympho-proliferative disorders and in hypoxic conditions
2014 Fimognari, Carmela; Turrini, Eleonora; Sestili, Piero; Calcabrini, Cinzia; Carulli, Giovanni; Fontanelli, Giulia.; Rousseau, Martina.; Cantelli-Forti, Giorgio; Hrelia, Patrizia
Micronucleus frequency in human peripheral blood lymphocytes as a biomarker for the early detection of colorectal cancer risk.
2014 Maffei F;Zolezzi Moraga JM;Angelini S;Zenesini C;Musti M;Festi D;Cantelli-Forti G;Hrelia P
Neuroprotection by 6-(methylsulfinyl)hexyl isothiocyanate in a 6-hydroxydopamine mouse model of Parkinson׳s disease.
2014 Morroni F;Sita G;Tarozzi A;Cantelli-Forti G;Hrelia P
Sulforaphane induces apoptosis in rhabdomyosarcoma and restores TRAIL-sensitivity in the aggressive alveolar subtype leading to tumor elimination in mice.
2014 Bergantin E; Quarta C; Nanni C; Fanti S; Pession A; Cantelli-Forti G; Tonelli R; Hrelia P
Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapy
2013 Angelini S; Soverini S; Ravegnini G; Barnett M; Turrini E; Thornquist M; Pane F; Hughes TP; White DL; Radich J; Kim DW; Saglio G; Cilloni D; Iacobucci I; Perini G; Woodman R; Cantelli-Forti G; Baccarani M; Hrelia P; Martinelli G
Blood Biomarkers Linked to Oxidative Stress and Chronic Inflammation for Risk Assessment of Colorectal Neoplasia
2013 Francesca Maffei;Sabrina Angelini;Giorgio Cantelli Forti;Patrizia Hrelia
Hemidesmus indicus induces apoptosis as well as differentiation in a human promyelocytic leukemic cell line
2013 Ferruzzi L.; Turrini E.; Burattini S.; Falcieri E.; Poli F.; Mandrone M.; Sacchetti G.; Tacchini M.; Guerrini A.; Gotti R.; Hrelia P.; Cantelli-Forti G.; Fimognari C.
Inflammation-induced alteration of astrocyte mitochondrial dynamics requires autophagy for mitochondrial network maintenance.
2013 Motori E; Puyal J; Toni N; Ghanem A; Angeloni C; Malaguti M; Cantelli-Forti G; Berninger B; Conzelmann KK; Götz M; Winklhofer KF; Hrelia S; Bergami M.
Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease
2013 Morroni F.; Tarozzi A.; Sita G.; Bolondi C.; Zolezzi Moraga JM; Cantelli-Forti G.; Hrelia P.
Polymorphisms in OCTN1 and OCTN2 transporters genes are associated with prolonged time to progression in unresectable Gastrointestinal stromal tumours treated with imatinib therapy
2013 Angelini S; Pantaleo MA; Ravegnini G; Zenesini C; Cavrini G; Nannini M; Fumagalli E; Palassini E; Saponara M; Di Battista M; Casali PG; Hrelia P; Cantelli-Forti G; Biasco G
Antitumor Activity of Sustained N-Myc Reduction in Rhabdomyosarcomas and Transcriptional Block by Antigene Therapy
2012 R. Tonelli; A. McIntyre; C. Camerin; Z.S. Walters; K. Di Leo; J. Selfe; S. Purgato; E. Missiaglia; A. Tortori; J. Renshaw; A. Astolfi; K.R. Taylor; S. Serravalle; R. Bishop; C. Nanni; L.J. Valentijn; A. Faccini; I. Leuschner; S. Formica; Jorge S Reis-Filho9; V. Ambrosini; K. Thway; M. Franzoni; B. Summersgill; R. Marchelli; P. Hrelia; G. Cantelli-Forti; S. Fanti; R. Corradini; A. Pession; J. Shipley
Environmental exposure to benzene, micronucleus formation and polymorphisms in DNA-repair genes: A pilot study
2012 S. Angelini; F. Maffei; J.L. Bermejo; G. Ravegnini; D. L’Insalata; G. Cantelli-Forti; F. S. Violante; P. Hrelia
Local rearrangement of mitochondrial networks marks the reactivity of astrocytes toward inflammation
2012 Motori E.; Conzelmann K.K.; Garthe A.; Berninger B.; Cantelli Forti G.;Angeloni C.; Malaguti M.; Gotz M.; Winklhofer K.; Hrelia S.
Metabolic and toxicological considerations of botanicals in anticancer therapy.
2012 FIMOGNARI C.; L. FERRUZZI; E. TURRINI; G. CARULLI; M. LENZI; P. HRELIA; G. CANTELLI FORTI
Neuroprotective effects of erucin against 6-hydroxydopamine-induced oxidative damage in a dopaminergic-like neuroblastoma cell line.
2012 TAROZZI A.; F. MORRONI; C. BOLONDI; G. SITA; P. HRELIA; A. DJEMIL; G. CANTELLI FORTI
Sulforaphane potentiates RNA damage induced by different xenobiotics.
2012 FIMOGNARI C.; M. LENZI; P. SESTILI; E. TURRINI; L. FERRUZZI; P. HRELIA; G. CANTELLI FORTI
Chemioprevenzione delle patologie cronico degenerative: ruolo del nutraceutico sulforafane
2011 Cantelli Forti G.; Leoncini E.; Fimognari C.; Hrelia P.; Hrelia S.
Mitochondrial pathway mediates the antileukemic effects of Hemidesmus Indicus, a promising botanical drug.
2011 FIMOGNARI C.; M. LENZI; L. FERRUZZI; E. TURRINI; P. SCARTEZZINI; F. POLI; R. GOTTI; A. GUERRINI; G. CARULLI; V. OTTAVIANO; G. CANTELLI FORTI; P. HRELIA